Live feed08:00:00·58mPRReleasevia QuantisnowMonopar Therapeutics Receives FDA Rare Pediatric Disease Designation for ALXN1840 for the Treatment of Wilson DiseaseByQuantisnow·Wall Street's wire, on your screen.MNPR· Monopar Therapeutics Inc.Health Care
